A detailed history of United Capital Financial Advisers, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 174,626 shares of BMY stock, worth $10.1 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
174,626
Previous 164,594 6.09%
Holding current value
$10.1 Million
Previous $6.84 Million 32.2%
% of portfolio
0.05%
Previous 0.06%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$39.66 - $51.75 $397,869 - $519,156
10,032 Added 6.09%
174,626 $9.04 Million
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $1.42 Million - $1.88 Million
-35,389 Reduced 17.7%
164,594 $6.84 Million
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $344,784 - $390,918
7,186 Added 3.73%
199,983 $10.8 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $13.3 Million - $15.8 Million
-273,772 Reduced 58.68%
192,797 $9.89 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $1.47 Million - $1.65 Million
-25,476 Reduced 5.18%
466,569 $27.1 Million
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $2.38 Million - $2.64 Million
-37,372 Reduced 7.06%
492,045 $31.5 Million
Q1 2023

Aug 14, 2023

BUY
$65.71 - $74.53 $1.45 Million - $1.65 Million
22,105 Added 4.49%
514,150 $35.6 Million
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $948,523 - $1.08 Million
14,435 Added 2.8%
529,417 $36.7 Million
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $315,624 - $373,743
-4,609 Reduced 0.89%
514,982 $37 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $2,617 - $1.55 Million
-20,134 Reduced 3.73%
519,591 $36.9 Million
Q2 2022

Aug 11, 2022

BUY
$72.62 - $79.98 $819,516 - $902,574
11,285 Added 2.14%
539,725 $41.6 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $561,189 - $672,916
-9,128 Reduced 1.7%
528,440 $38.6 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $2.65 Million - $3.09 Million
-49,424 Reduced 8.42%
537,568 $33.5 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $700,572 - $820,630
-11,840 Reduced 1.98%
586,992 $34.7 Million
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $579,106 - $630,646
-9,354 Reduced 1.54%
598,832 $40 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $39,045 - $43,914
658 Added 0.11%
608,186 $38.4 Million
Q4 2020

Feb 17, 2021

SELL
$57.74 - $65.43 $713,550 - $808,583
-12,358 Reduced 1.99%
607,528 $37.7 Million
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $727,178 - $805,809
-12,662 Reduced 2.0%
619,886 $37.4 Million
Q2 2020

Aug 13, 2020

SELL
$54.82 - $64.09 $4.24 Million - $4.95 Million
-77,260 Reduced 10.88%
632,548 $37.2 Million
Q1 2020

May 15, 2020

BUY
$46.4 - $67.43 $2.41 Million - $3.5 Million
51,943 Added 7.9%
709,808 $39.6 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $7.83 Million - $10.2 Million
159,113 Added 31.9%
657,865 $42.2 Million
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $16.9 Million - $20 Million
-394,623 Reduced 44.17%
498,752 $25.3 Million
Q2 2019

Aug 13, 2019

BUY
$44.62 - $49.34 $17 Million - $18.8 Million
380,918 Added 74.33%
893,375 $40.5 Million
Q1 2019

May 14, 2019

BUY
$45.12 - $53.8 $7.14 Million - $8.51 Million
158,233 Added 44.67%
512,457 $24.4 Million
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $916,639 - $1.19 Million
-18,799 Reduced 5.04%
354,224 $18.4 Million
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $373,746 - $421,557
-6,772 Reduced 1.78%
373,023 $23.2 Million
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $1.78 Million - $2.22 Million
-35,175 Reduced 8.48%
379,795 $21 Million
Q1 2018

May 15, 2018

BUY
$59.92 - $68.98 $1.65 Million - $1.9 Million
27,567 Added 7.12%
414,970 $26.2 Million
Q4 2017

Feb 13, 2018

BUY
$59.94 - $65.35 $583,995 - $636,705
9,743 Added 2.58%
387,403 $23.9 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $5.35 Million - $6.17 Million
96,827 Added 34.48%
377,660 $24.1 Million
Q2 2017

Aug 14, 2017

BUY
N/A
280,833
280,833 $15.6 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.